Carbiotix AB
- Jurisdiction
Sweden - ISIN
SE0013016128 (CRBX.ST )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
1
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
1
/ 7
Profile
Carbiotix AB is a pre-clinical stage therapeutics company. Read full profile
Stock price
Fundamentals
- Net revenue
€19.19K - Gross margin
-1,240.8% - EBIT
-€1.40M - EBIT margin
-7,281.9% - Net income
-€1.40M - Net margin
-7,281.8%
Statement period: - (published )
Dividends
No dividend payouts